{"id":"NCT00092118","sponsor":"Organon and Co","briefTitle":"The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265)","officialTitle":"A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-10","primaryCompletion":"2004-05","completion":"2004-05","firstPosted":"2004-09-24","resultsPosted":"2010-07-23","lastUpdate":"2022-02-03"},"enrollment":1992,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Rhinitis, Allergic, Perennial"],"interventions":[{"type":"DRUG","name":"Montelukast","otherNames":[]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine the effect of an approved medication on the symptoms of perennial allergic rhinitis (an inflammation of the mucous membrane of the nose similar to that found in hay fever except that symptoms persist throughout the year), in patients who have a history of perennial allergic rhinitis.","primaryOutcome":{"measure":"Mean Change From Baseline in Daytime Nasal Symptoms Score Averaged Over the 6-week Treatment Period in Patients With Perennial Allergic Rhinitis","timeFrame":"6 week treatment period (from baseline though the end of week 6)","effectByArm":[{"arm":"Placebo","deltaMin":-0.37,"sd":null},{"arm":"Montelukast 10 mg","deltaMin":-0.44,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["16400895"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":990},"commonTop":[]}}